|
2024 Journal Article Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipientsDousset, Lea, Chambers, Daniel C., Webster, Angela, Isbel, Nicole, Campbell, Scott, Duarte, Carla, Collins, Louisa, Damian, Diona, Tseng, Anne, Karlsen, Emma, Ilinsky, Olga Victoria, Brown, Susan, Schaider, Helmut, Soyer, H. Peter, Ospino, Daniel Ariza, Hogarth, Sam, Chong, Alvin H., Mar, Victoria, McKenzie, Scott, Gin, Douglas, Fernandez-Penas, Pablo, Kern, Johannes S., Loewe, Katja, Roy, Edwige, Herschtal, Alan and Khosrotehrani, Kiarash (2024). Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients. Trials, 25 (1) 789. doi: 10.1186/s13063-024-08619-3 |
|
2024 Journal Article Consensus versus discordance in the classification of borderline melanocytic lesions between dermatopathologists and artificial intelligence: An Australian cohort studyMuller, Nicholas M., Rutjes, Chantal, Tan, Samuel X., Vipulaguna, Nisal, Oloruntoba, Ayooluwatomiwa, Nguyen, Toan, von Schuckmann, Lena, Betz‐Stablein, Brigid, Khosrotehrani, Kiarash, Ge, Zongyuan, Soyer, H. Peter and Katz, Ian (2024). Consensus versus discordance in the classification of borderline melanocytic lesions between dermatopathologists and artificial intelligence: An Australian cohort study. Journal of the European Academy of Dermatology and Venereology. doi: 10.1111/jdv.20412 |
|
2024 Journal Article Generating skin‐derived precursor‐like cells from human‐induced pluripotent stem cell‐derived skin organoidsAhmed, Imaan A., Sun, Jane, Kong, Min Jie, Khosrotehrani, Kiarash and Shafiee, Abbas (2024). Generating skin‐derived precursor‐like cells from human‐induced pluripotent stem cell‐derived skin organoids. Experimental Dermatology, 33 (11) e70017, e70017. doi: 10.1111/exd.70017 |
|
2024 Journal Article Dr. Kiarash KhosrotehraniKhosrotehrani, Kiarash (2024). Dr. Kiarash Khosrotehrani. The Nishinihon Journal of Dermatology, 86 (5), 517-518. doi: 10.2336/nishinihonhifu.86.517 |
|
2024 Journal Article A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapyRossi, Gustavo R., Sun, Jane, Lin, Cheng‐Yu, Wong, Joshua K.M., Alim, Louisa, Lam, Pui Yeng, Khosrotehrani, Kiarash, Wolvetang, Ernst, Cheetham, Seth W., Derrick, Emily B., Amoako, Akwasi, Lehner, Christoph, Brooks, Andrew J., Beavis, Paul A. and Souza‐Fonseca‐Guimaraes, Fernando (2024). A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy. Immunology & Cell Biology, 102 (10), 1-11. doi: 10.1111/imcb.12820 |
|
2024 Journal Article Exploring the germline genetics of in situ and invasive cutaneous melanoma: a genome-wide association study meta-analysisIngold, Nathan, Seviiri, Mathias, Ong, Jue Sheng, Neale, Rachel E., Pandeya, Nirmala, Whiteman, David C., Olsen, Catherine M., Martin, Nicholas G., Duffy, David L., Khosrotehrani, Kiarash, Hayward, Nicholas, Montgomery, Grant W., MacGregor, Stuart and Law, Matthew H. (2024). Exploring the germline genetics of in situ and invasive cutaneous melanoma: a genome-wide association study meta-analysis. JAMA Dermatology, 160 (9), 964-971. doi: 10.1001/jamadermatol.2024.2601 |
|
2024 Journal Article Diversifying dermatology: Improving skin of colour representationSusanto, Alyssa, Nathan, Vaishnavi, Janda, Monika, Khosrotehrani, Kiarash, McMeniman, Erin, Soyer, H. Peter and Betz‐Stablein, Brigid (2024). Diversifying dermatology: Improving skin of colour representation. Australasian Journal of Dermatology, 65 (7), e208-e210. doi: 10.1111/ajd.14356 |
|
2024 Journal Article Management of skin toxicities in cancer treatment: an Australian/New Zealand perspectiveLadwa, Rahul, Fogarty, Gerald, Chen, Peggy, Grewal, Gurpreet, McCormack, Chris, Mar, Victoria, Kerob, Delphine and Khosrotehrani, Kiarash (2024). Management of skin toxicities in cancer treatment: an Australian/New Zealand perspective. Cancers, 16 (14) 2526, 1-16. doi: 10.3390/cancers16142526 |
|
2024 Journal Article Distinct roles of SOX9 in self-renewal of progenitors and mesenchymal transition of the endotheliumZhao, Jilai, Sormani, Laura, Jacquelin, Sebastien, Li, Haiming, Styke, Cassandra, Zhou, Chenhao, Beesley, Jonathan, Oon, Linus, Kaur, Simranpreet, Sim, Seen-Ling, Wong, Ho Yi, Dight, James, Hashemi, Ghazaleh, Shafiee, Abbas, Roy, Edwige, Patel, Jatin and Khosrotehrani, Kiarash (2024). Distinct roles of SOX9 in self-renewal of progenitors and mesenchymal transition of the endothelium. Angiogenesis, 27 (3), 1-16. doi: 10.1007/s10456-024-09927-7 |
|
2024 Journal Article An optimized protocol for generating appendage-bearing skin organoids from human-induced pluripotent stem cellsAhmed, Imaan, Sun, Jane, Brown, Jason, Khosrotehrani, Kiarash and Shafiee, Abbas (2024). An optimized protocol for generating appendage-bearing skin organoids from human-induced pluripotent stem cells. Biology Methods and Protocols, 9 (1) bpae019, 1-10. doi: 10.1093/biomethods/bpae019 |
|
2024 Journal Article Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanomaTan, Samuel X., Chong, Sharene, Rowe, Casey, Galbraith, Jack, Dight, James, Zhou, Chenhao, Malt, Maryrose, Smithers, Bernard Mark and Khosrotehrani, Kiarash (2024). Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma. Experimental Dermatology, 33 (3) e15041, 1-7. doi: 10.1111/exd.15041 |
|
2024 Journal Article Treatment of lichen planopilaris with Janus kinase inhibitorsGonzalez Matheus, Gabriela A. and Khosrotehrani, Kiarash (2024). Treatment of lichen planopilaris with Janus kinase inhibitors. Australasian Journal of Dermatology, 65 (4), 381-383. doi: 10.1111/ajd.14240 |
|
2023 Journal Article pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanomaTan, Samuel X., Chong, Sharene, Rowe, Casey, Claeson, Magdalena, Dight, James, Zhou, Chenhao, Rodero, Mathieu P., Malt, Maryrose, Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2023). pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma. Melanoma Research, 33 (6), 506-513. doi: 10.1097/cmr.0000000000000915 |
|
2023 Journal Article The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensusDreno, Brigitte, Khosrotehrani, Kiarash, De Barros Silva, Giselle, Wolf, Julie Ryan, Kerob, Delphine, Trombetta, Mark, Atenguena, Etienne, Dielenseger, Pascale, Pan, Meng, Scotte, Florian, Krakowski, Ivan and Lacouture, Mario (2023). The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Supportive Care in Cancer, 31 (12) 672. doi: 10.1007/s00520-023-08116-4 |
|
2023 Journal Article Prognosis of naevoid melanomasCook, Martin G., Grant, Megan, Sylvestre, Yvonne, Akhras, Victoria, Khosrotehrani, Kiarash, Hughes, Maria Celia B, Malt, Maryrose, Smithers, B. Mark, Massi, Daniela, De Giorgi, Vincenzo, Marais, Richard and Green, Adele C. (2023). Prognosis of naevoid melanomas. Pathology - Research and Practice, 251 154881, 154881. doi: 10.1016/j.prp.2023.154881 |
|
2023 Journal Article Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newbornsChand, Kirat, Patel, Jatin, Matthews, Kate, Nano, Rachel, Musco, Hannah, Khosrotehrani, Kiarash, Colditz, Paul and Wixey, Julie (2023). Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newborns. IBRO Neuroscience Reports, 15, S171-S171. doi: 10.1016/j.ibneur.2023.08.249 |
|
2023 Journal Article Patterns and cost of care according to keratinocyte cancer risk stratification in a volunteer population screening clinic: real‐world data from the TRoPICS studyLee, Ruby Chia‐Lin, Liyanage, Upekha, Fry, Kirsty, Brown, Susan, von Schuckmann, Lena, Spelman, Lynda, Soyer, H. Peter, Neale, Rachel E., Gordon, Louisa G., Whiteman, David C., Olsen, Catherine M., Janda, Monika and Khosrotehrani, Kiarash (2023). Patterns and cost of care according to keratinocyte cancer risk stratification in a volunteer population screening clinic: real‐world data from the TRoPICS study. Australasian Journal of Dermatology, 64 (3), 389-396. doi: 10.1111/ajd.14054 |
|
2023 Journal Article Metamorphosis of topical semisolid products—understanding the role of rheological properties in drug permeation under the “in use” conditionJin, Xuping, Alavi, Seyed Ebrahim, Shafiee, Abbas, Leite-Silva, Vania Rodrigues, Khosrotehrani, Kiarash and Mohammed, Yousuf (2023). Metamorphosis of topical semisolid products—understanding the role of rheological properties in drug permeation under the “in use” condition. Pharmaceutics, 15 (6) 1707, 1707. doi: 10.3390/pharmaceutics15061707 |
|
2023 Journal Article The association between <scp>BRAF‐V600E</scp> mutations and death from thin (≤1.00 mm) melanomas: a nested case‐case study from Queensland, AustraliaClaeson, M., Tan, S. X., Lambie, D., Brown, S., Walsh, M. D., Baade, P. D., Pandeya, N., Whitehead, K. J., Soyer, H. P., Smithers, B. M., Whiteman, D. C. and Khosrotehrani, K. (2023). The association between BRAF‐V600E mutations and death from thin (≤1.00 mm) melanomas: a nested case‐case study from Queensland, Australia. Journal of the European Academy of Dermatology and Venereology, 37 (9), e1168-e1172. doi: 10.1111/jdv.19173 |
|
2023 Journal Article Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trialCox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial. Journal of the European Academy of Dermatology and Venereology, 143 (5), S259-e975. doi: 10.1111/jdv.19041 |
